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INTRODUCTION
The role of the renin-angiotensin system in renal hypertension has been
investigated for many years but the relationship of the renin-angiotensin
system to adrenocortical function has received less attention. In 1951,
Deane and Masson,4 using the rat as an experimental animal, reported that
encapsulation of the kidney, a procedure which results in hypertension
presumably through release of renin, and injections of crude renin prep-
arations both produced enlargement of the zona glomerulosa of the adrenal
gland, the site of aldosterone formation. Hartroft and co-workers" noted
that salt loading in the rat decreased both the granulations of the juxta-
glomerular apparatus (the probable site of renin formation) and the con-
tent of renin in the kidney, while sodium deprivation increased the granula-
tions and the content of renin. An excellent review by Tobian1' has sum-
marized the data concerning the possible role of the renin-angiotensin sys-
tem in electrolyte metabolism and hypertension. Recently prolonged infu-
sions of synthetic angiotensin into man have been reported as producing
a pressor response and an increase in aldosterone excretion and secre-
tion."'10 It is a possibility that the aldosterone effect was an indirect one
through angiotensin stimulating ACTH release from the pituitary. In fact,
Geneste found that the angiotensin infusion also increased urinary tetrahy-
drocortisol excretion. Experiments conducted independently by Davis and
co-workers8 and the authors' have implicated the kidney and the renin-
angiotensin system in the increased aldosterone secretion that occurs fol-
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lowing hemorrhage in the hypophysectomized dog. The present report con-
cerns a preliminary study of the effect of angiotensin II on adrenocortical
secretion in the hypophysectomized, nephrectomized dog.
PROCEDURE AND METHOD
Angiotensin II Experiments. Mongrel male dogs weighing about 12 kilograms
underwent a left nephrectomy one to four weeks prior to the experimental day. On
the experimental day, each dog was anesthetized with Nembutal, acutely hypophysec-
tomized by the transbuccal route, following which the right kidney was removed and
the right lumboadrenal vein cannulated by the method of Nelson and Hume.' The
femoral artery was cannulated for continuous blood pressure recording using a Grass
Model 5 Polygraph and a Statham strain gauge, and the femoral vein for administra-
tion of blood or angiotensin II. During the control period, two 10-15 ml. samples of
adrenal vein blood were collected at 20-minute intervals. The dog was then hemor-
rhaged 15 ml./kg. body weight and three post-hemorrhage samples of adrenal vein
blood collected at 20- to 30-minute intervals. Following the last sample, isotonic saline
solutions containing 3.3 Ag of synthetic angiotensin II* per ml. were infused through
a constant infusion pump. Two more adrenal vein blood samples were collected, one
during the infusion and the other one-half hour after its completion.
In one experiment ($224), following the last post-hemorrhage sample, 10 sg of
angiotensin II in 3 ml. of isotonic saline was administered intravenously over one
minute and adrenal vein blood collected for 18 minutes. One-half hour after the
angiotensin II injection, 5 milliunits of Upjohn ACTH in 1 ml. of isotonic saline were
administered intravenously over one minute and adrenal vein blood was collected for
18 minutes.
ACTH experiments. The effect of graded doses of Upjohn ACTH on adrenocortical
function was studied. On the experimental day, Dog $111 was anesthetized with
Nembutal, hypophysectomized through the transbuccal route, and the right lumbo-
adrenal vein cannulated. At one-half hour intervals a dose of ACTH (5 my. per ml. of
saline) was injected intravenously and adrenal vein blood collected from four to
fourteen minutes following the injection.
Following a study of the effect of acute respiratory acidosis on adrenocortical
secretion of a normal dog (Dog $13) the effect of intravenous administration of 10 and
1000 nm, of Armour ACTH in saline was studied. On the experimental day, the dog
was anesthetized with Nembutal, the right lumboadrenal vein cannulated, and a tracheal
cannula inserted for regulation of the dogs respirations by a respiratory pump. During
the control period, 100 per cent oxygen was administered through the tracheal cannula.
The dog was then respired with a mixture of 90 per cent oxygen and 10 per cent
carbon dioxide for approximately one and one-half hours. Three samples of adrenal
venous blood were collected in the control and the respiratory acidosis periods at one-
half hour intervals. Following the respiratory acidosis period, the dog was respired
with 100 per cent oxygen. After twenty minutes a "control' sample of adrenal venous
* Synthetic angiotensin II (Ciba-Hypertension II) was obtained through the
courtesy of Ciba Pharmaceutical Inc.
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blood was collected. Ten milliunits of Armour ACTH in 1 ml. of isotonic saline was
then injected intravenously. Nine minutes later, a five-minute collection of adrenal
venous blood was begun. Approximately seventeen minutes after the initial injection,
1000 milliunits of Armour ACTH in 1 ml. of isotonic saline was administered intra-
venously and collection of adrenal venous blood started five minutes later.
In all dogs, immediately after the collection of each sample of adrenal vein blood, an
equal volume of dog donor blood was administered to avoid the effect of repeated small
hemorrhages. There was no replacement of the blood removed in the large hemorrhage
in the hypophysectomized, nephrectomized dogs.
TABLE 1. ANGIOTENSIN EXPERIMENT
Dog $215-12 Kg. Hypophysectomized, Nephrectomized
Adrenal 17-OH
B.P.* plasma flow** Corticoidst
mm./Hg ml./min. Ig./min.
65/25 0.9 0
70/30 0.8 0
Angiotensin infusion 1.67 i&g./min.
150/100 0.7 2.2
100/60 1.4 0
Angiotensin infusion 0.42 Ag./min.
145/100 1.1 0.8
105/55 1.5 0
Angiotensin infusion 0.17 /Ag./min.
120/70 1.3 0
1.0 0
* Blood pressure.
** Adrenal plasma flow was calculated from the adrenal
t 17-OH corticoids is used for 17-hydroxycorticoids.
Corticosterone Aldo
Ag.1min. mfxg
0.058
0.048
Total 28&g.
0.67
0.078
Total 6IAg.
0.27
0.055
Total 2Ag.
0.056
0.067
blood flow and hematocrit.
Corticosterone and aldosterone were measured in adrenal vein plasma by the isotope
derivative method of Kliman and Peterson, 17-hydroxycorticoids by the Silber-Porter
method.'7 Secretory rates were calculated from the concentration and the plasma flow
per minute.
RESULTS
In Dog #111 only are the results of the entire experiment shown. The
effect of hemorrhage on adrenocortical secretions of the hypophysectomized,
nephrectomized dogs will be published elsewhere as part of a larger series
of experiments. The possibility that the prior experimental conditions in-
fluenced the pattern of response of the adrenal cortex to angiotensin or
ACTH cannot be excluded.
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Angiotensin II experiments. The infusion of approximately 30,ug of
Angiotensin II stimulated secretions of 17-hydroxycorticoids, corticos-
terone, and aldosterone in three of the hemorrhaged, hypophysectomized,
nephrectomized dogs (Tables 1, 2, 3). Cessation of the infusion resulted
in the return of the secretory levels to the base line. In each dog, a lower
dose of Angiotensin II was found which reduced the increment in 17-
hydroxycorticoids and corticosterone secretion. However, aldosterone se-
TABLE 2. ANGIOTENsIN EXPERIMENT
Dog p18-12 Kg. Hypophysectomized, Nephrectomized
Adrenal 17-OH
Time B.P.* plasma flow** Corticoidst Corticosterone Aldosterone
mins. mm./Hg ml./min. Ig./min. a'g./min. mIsg./min.
-40 90/45 0.7 0 0.031 1.9
-10 100/50 0.6 0 0.044 0.7
0-19 Angiotensin infusion 1.67 Ag./min. Total 32,*g.
6 185/125 0.3 2.6 0.81 23
49 100/45 .... ...
49-78 Angiotensin infusion 0.42 ig./min. Total 12Ag.
54 150/95 0.2 0.2 0.14 18
* Blood pressure.
** Adrenal plasma flow was calculated from the adrenal blood flow and hematocrit.
t 17-OH corticoids is used for 17-hydroxycorticoids.
cretion was stimulated to approximately the same extent. In fact, in Dog
#223 (Table 3) an infusion of 3Ag of Angiotensin II stimulated only
aldosterone secretion. In the hemorrhaged, hypophysectomized, nephrec-
tomized Dog #224, a comparison between the effects of a single injection
of Angiotensin II and 5 milliunits of ACTH on adrenocortical secretions
was made. Angiotensin stimulated all three parameters, 17-hydroxycorti-
coid, corticosterone and aldosterone secretion, while ACTH stimulated only
17-hydroxycorticoid and ACTH secretion (Table 4).
Angiotensin II, a potent pressor substance, always produced a rise in
blood pressure, but not necessarily to levels abnormal for the dog. Two
of the dogs were hypotensive prior to the initial angiotensin infusions, while
the blood pressure of Dog #223 had returned to the pre-hemorrhage level
of 150/lOOmm./Hg. In this dog, 3,g of Angiotensin II increased aldoster-
one secretin to 33 mpg./min. while only raising the blood pressure to
155/95 mm./Hg. Although this was an increase over the blood pressure
389YALE JOURNAL OF BIOLOGY AND MEDICINE
of 125/45 recorded immediately prior to the angiotensin infusion, the level
is comparable to the "control" blood pressure of 150/lOOmm./Hg. when
the aldosterone secretory rate was only 6m,ug./min.
The effect of Angiotensin II upon adrenal blood flow was variable.
ACTH experiments. Commercial ACTH produced a dose response pat-
tern of adrenocortical secretion different from Angiotensin II. Under dif-
ferent experimental conditions, both preparations of ACTH produced simi-
TABLE 3. ANGIOTENSIN EXPERIMENT
Dog $223-11 Kg. Hypophysectomized, Nephrectomized
B.P.*
mm./Hg
110/60
150/100
Angiotensin
190/150
150/75
Angiotensin
190/145
100/30
Adrenal 17-OH
plasma flow** Corticoidst
ml./min. 0g.lmin.
0.9 0
0. 0
infusion 1.67 Ag./min.
0.5 2.1
0.2 0
infusion 0.42 i&g./min.
1.4 3.0
1.3 0.4
125/45
Angiotensin infusion 0.167 og./min.
155/95 0.8 0.2
Corticosterone Aidosterone
Mg./min. mLg./min.
0.023 3
0.017 6
Total 30sAg.
0.40 30
0.010 15
Total 5,'g.
0.57 61
0.028 4
Total 3iAg.
0.010 33
* Blood pressure.
** Adrenal plasma flow was calculated from the adrenal blood flow and hematocrit.
t 17-OH corticoids is used for 17-hydroxycorticoids.
lar results (Tables 4 and 5). The largest dose stimulated both glucocorti-
coid secretion (17-hydroxycorticoids or corticosterone). There were no
changes in arterial blood pressure following ACTH administration.
The volumes of isotonic saline administered were small in all experiments
and probably did not influence the results. Moreover, administration of
100 ml. of isotonic saline over one minute to each of three hypophysec-
tomized, nephrectomized dogs by the authors had no significant effect on
adrenocortical secretions.
DISCUSSION
Angiotensin is a decapeptide that is formed in vivo by the action of renin,
an enzyme released from the kidney, on the a2 globulins of blood. A specific
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converting enzyme in plasma converts angiotensin I into the potent pressor
octapeptide angiotensin II.'8
The pattern of adrenocortical response to short term intravenous admin-
istration of synthetic angiotensin II depended upon the dose administered.
In each of three dogs, a dose of about 30ug. of angiotensin II stimulated
both glucocorticoid and aldosterone secretion while a lower dose stimulated
primarily aldosterone secretion. The values of glucocorticoid secretion at-
TABLE 4. ANGIOTENSIN AND ACTH EXPERIMENT
Dog $224-10 Kg. Hypophysectomized, Nephrectomized
Adrenal 17-OH
Time B.P.* plasma flow** Corticoidst Corticosterone Aldosterone
mins. mm./Hg ml./min. Mg./min. lAg./min. mt&g./min.
-60 125/70 1.1 0 0.067 0
-30 125/55 1.2 0 0.051 0
0 120/55 Angiotensin II 10 Ag. over 1 minute
0-18 151/93i: 1.5 1.4 0.30 17
18 120/65 ..
30 125/60 ACTH¶f 5 mi. over 1 minute
30-48 120/55 1.3 3.2 0.49 3
48 125/60 ..
60 125/60 1.4 0.1 0.043 1
* Blood pressure.
** Adrenal plasma flow was calculated from the adrenal blood flow and hematocrit.
t 17-OH corticoids is used for 17-hydroxycorticoids.
*Average blood pressure for 18 minutes. Peak blood pressure 190/135 mm./Hg
occurred within one minute, lasted for two minutes and gradually declined thereafter.
¶Lyophilized Upjohn Adrenocorticotropin Hormone.
tained even with the 3O0,g. dose were still well below the maximum secre-
tory rate. However, the aldosterone secretory rates attained were as high
or higher than the secretory rates following hemorrhage in the hypophysec-
tomized dog.'8 It should be kept in mind, however, that the response of
the adrenal to short term infusions of angiotensin II may be different from
the response to a prolonged infusion. A study by Hilton, et al.7 using the
perfused isolated dog adrenal showed that the stimulatory effect of a vaso-
pressor infusion on cortisol secretion was transient and not sustained by a
prolonged infusion.
Similarly the pattern of adrenocortical response to intravenous admin-
istration of ACTH is dose-dependent. Like angiotensin, the larger doses
of ACTH stimulated both glucocorticoid and aldosterone secretion while,
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in contrast to angiotensin, the smaller doses stimulated only glucocorticoid
secretion. There were smaller doses of ACTH which even produced a
higher glucocorticoid secretory rate than the 30,ug of angiotensin yet did
not stimulate aldosterone secretion. It should be pointed out that the ex-
perimental design of the angiotensin and ACTH experiments differed. It
is possible that the metabolic state of the adrenal gland influenced the re-
sults. This possibility did occur in a previous study by the authors' in
TABLE 5. ACTH EXPERIMENTS
Dog $111-12 Kg. Hypophysectomized
Adrenalplas- 17-OH Cortico-
Treatment Time ma flow* Corticoids** sterone Aldosterone
mins. ml./min. IAg./min. Ag./min. mIg./min.
Control - 1.7 1.2 0.11 15
1 m/A.t ACTHt 0 1.4 0.6 0.19 10
5 mu. ACTH 30 1.4 2.5 0.81 8
10 my. ACTH 60 1.3 5.9 1.74 7
25 mo. ACTH 90 1.2 7.1 2.17 10
2 mys. ACTH 120 1.0 0.6 0.31 11
0 150 1.3 0.5 0.13 11
50 mn. ACTH 180 1.4 9.3 3.14 33
Dog $13 "Normal"
Control -8 0.9 .. 1.1 40
10 mi'.t ACTH¶f 0
9 1.4 .. 3.2 31
1000 mi. ACTH 17
22 1.3 .. 4.1 116
* Adrenal plasma flow was calculated from the adrenal blood flow and hematocrit.
** 17-OH corticoids is used for 17-hydroxycorticoids.
t m/A. = International milliunits.
t Lyophilized Upjohn Adrenocorticotropin Hormone.
¶1 Lyophilized Armour Adrenocorticotrophin Hormone.
which 1 unit of ACTH administered to hemorrhaged, normal dogs who
were maximally secreting glucocorticoids, stimulated only aldosterone secre-
tion. However, 1 unit of ACTH administered to hemorrhaged hypophysec-
tomized dogs always stimulated both glucocorticoid and aldosterone secre-
tion.
Angiotensin II is the most potent vasopressor material known. Nephrec-
tomy and hemorrhage increase the sensitivity of animals to angiotensin.'
It is not surprising, therefore, that a dose as small as 3,Ag produced a pres-
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sor effect. Although the present experiments do not rule out the possibility
that the rise in blood pressure per se stimulated aldosterone secretion, sev-
eral lines of evidence do not support this possibility. Laragh, et al.' have
shown in man that the pressor agents norepinephrine, epinephrine, ephe-
drine, and vasopressin had variable effects on alosterone secretion except
in sodium-depleted subjects with high aldosterone secretion in whom me-
dullary type hormones generally produced a fall. Infusion of angiotensin
II always produced a rise in aldosterone secretion. Moreover, Newman,
et al.' demonstrated that norepinephrine does not increase aldosterone se-
cretion in the dog, at least not in amounts which maintained the mean
arterial pressure at 100 mm. Hg. Barter, et al.' actually dissociated altera-
tions in blood pressure and aldosterone secretion in a specific experimental
situation. They reported that bilateral constriction of the common carotid
arteries in dogs with both thyrocarotid arterial junctions denervated, pro-
duced no increase in aldosterone secretion despite a rise in blood pressure
due to an intact Hering reflex. Constriction, with the nerves to the thyro-
carotid arterial junctions intact, resulted in increases in both aldosterone
secretion and blood pressure. The work of Hilton, et aL' dissociated the
cortisol stimulatory activity and the pressor action of several vasopressin
peptides in the isolated perfused dog adrenal. Moreover, acetyl arginine
(vasopressin) which has no pressor activity stimulated both cortisol and
aldosterone in one experiment. These authors also stated that oxytocin and
norepinephrine in doses sufficient to have pressor activity had no effect on
cortisol secretion. Finally, in a study of the effect of hemorrhage on adreno-
cortical secretion in hypophysectomized dogs, the authors? found that trans-
fusion of the shed blood did not cause a significant increase in adrenocorti-
cal secretions, including aldosterone, despite a modest elevation of blood
pressure and increased adrenal blood flow. Nevertheless, these experimen-
tal situations do not duplicate the present experiments and it remains to
be shown that the stimulatory effect on aldosterone secretion is specific for
angiotensin.
It is tempting to speculate that angiotensin II is the elusive aldosterone-
stimulating hormone. This hypothesis is supported by: (i) evidence'9 which
suggests that the juxtoglomerular apparatus is a "volume" receptor; (ii)
the hyperplasia of zona glomerulosa of the adrenal gland following renin
injections;' (iii) the aldosterone-stimulating effect of angiotensin II in
mand"' and the dog;8 and (iv) the increased secretions of aldosterone in
man in malignant hypertension" and in some cases of hypertension due to
unilateral renal vascular disease.9 However, if angiotensin II is the aldo-
sterone-stimulating hormone, a dose insufficient to have a pressor effect
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should be able to stimulate aldosterone secretion, since several stimuli which
increase aldosterone secretion are not associated with a pressor effect. Fur-
thermore, a prolonged infusion of angiotensin II should maintain an in-
creased secretory rate. Finally, and most important, it must be shown that
the kidney and the renin-angiotensin system are necessary for the physio-
logical stimuli which increase aldosterone secretion.
SUMMARY
The pattern of adrenocortical secretions produced by an infusion of
angiotensin II was dose-dependent. A dose of approximately 30Ftg. of
angiotensin II stimulated both glucocorticoid and aldosterone secretion.
Reduction in dosage reduced the increment in glucocorticoid secretion with-
out appreciably reducing the increment in aldosterone secretion. Angio-
tensin II always produced a pressor response.
The pattern of adrenocortical secretion produced by ACTH administra-
tion was also dose-dependent. Like angiotensin II, the larger doses of
ACTH stimulated both glucocorticoid and aldosterone secretion. In con-
trast to angiotensin II, the smaller doses stimulated only glucocorticoid
secretion. The possible role of the renin-angiotensin system in the regula-
tion of aldosterone secretion is briefly discussed.
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